Actively Recruiting
Low Intraocular Pressure Cataract Surgery With Zeiss Quatera in Glaucoma Patients
Led by Visionair Oogzorg · Updated on 2024-12-02
10
Participants Needed
1
Research Sites
59 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
You were selected to participate in this observational study because you suffer from glaucoma and cataracts. For the cataract you will have cataract surgery. This study will not affect your treatment, it will only collect data on what is performed before, during and after the procedure. The aim of this data collection is to demonstrate the safety of a new generation of cataract surgical devices in patients who also suffer from glaucoma. They are glaucoma patients who have an increased sensitivity to eye pressure increases both during and after surgery. The new surgical device makes it possible to safely perform cataract surgery under low pressures. This could, at least theoretically, provide an advantage for patients who also suffer from glaucoma.
CONDITIONS
Official Title
Low Intraocular Pressure Cataract Surgery With Zeiss Quatera in Glaucoma Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with glaucoma that are diagnosed with age-related cataract
You will not qualify if you...
- Unwilling to sign informed consent
- Functionally monophtalmic patient
- Endothelial dystrophy
- Active uveitis
- Known corticosteroid responder
- Presence of uncontrolled systemic disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Visionair Oogzorg
Geel, Belgium, 2400
Actively Recruiting
Research Team
K
Koen Willekens, Prof
CONTACT
S
Sien Boons
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here